ClinicalThought


Share

Program Content

Activities

  • ADCs for Advanced NSCLC
    The Use of Antibody–Drug Conjugates as Novel Therapies for Patients With Advanced NSCLC: Advanced Practice Professional Considerations
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 27, 2024

    Expires: September 26, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner